BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China
· Delayed Price · Currency is CNY 50.60
+1.92 (3.94%)
At close: May 13, 2025, 2:57 PM CST
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 21.36 billion as of May 13, 2025. Its market cap has increased by 79.47% in one year.
Market Cap
21.36B
Enterprise Value
22.89B
Revenue
1.19B
Ranking
n/a
PE Ratio
149.15
Stock Price
50.60
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 21.36B, an increase of 70.19%. That is a compound annual growth rate of 10.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 335.80B |
| Shenzhen Mindray Bio-Medical Electronics | 270.90B |
| WuXi AppTec | 168.36B |
| Zhangzhou Pientzehuang Pharmaceutical., | 125.22B |
| Aier Eye Hospital Group | 119.56B |
| Sichuan Biokin Pharmaceutical | 112.28B |
| Shanghai United Imaging Healthcare | 112.08B |
| Yunnan Baiyao Group Co.,Ltd | 101.81B |